MEMBRANE EXPRESSION OF HIV ENVELOPE GLYCOPROTEINS TRIGGERS APOPTOSIS IN CD4 CELLS

被引:186
作者
LAURENTCRAWFORD, AG
KRUST, B
RIVIERE, Y
DESGRANGES, C
MULLER, S
KIENY, MP
DAUGUET, C
HOVANESSIAN, AG
机构
[1] TRANSGENE SA, F-67000 STRASBOURG, FRANCE
[2] INST PASTEUR, DEPT AIDS & RETROVIRUSES, CNRS, UA 1157, F-75724 PARIS 15, FRANCE
[3] INSERM, U271, F-69424 LYON 03, FRANCE
[4] INST BIOL MOLEC & CELLULAIRE, CNRS, F-67084 STRASBOURG, FRANCE
关键词
D O I
10.1089/aid.1993.9.761
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytopathic effect of HIV-1 and HIV-2 in CD4+ lymphocytes has been shown to be associated with apoptosis or programmed cell death. Using different experimental conditions, we demonstrate here that apoptosis is triggered by cell membrane expression of the mature HIV envelope glycoproteins, gp120-gp41 complex, and their interaction with CD4 receptor molecules. Viral entry alone did not induce apoptosis but virus replication was required in order to produce the gp120-gp41 complex. Indeed, expression of the HIV env gene alone in the CD4+ T cell line (CEM) was sufficient for the induction of apoptosis. In general, syncytium formation and apoptosis induction were closely associated as both events require functional envelope glycoproteins and CD4 molecules. Nevertheless, apoptosis but not syncytium formation was suppressed by a monoclonal antibody against CD4 that does not affect gp120 binding. Furthermore, single-cell killing by apoptosis was observed in infected cell cultures treated with a monoclonal antibody against gp41, which completely abolishes the formation of syncytia. These results indicate that apoptosis is not the consequence of toxic effects induced by the formation of syncytia but is triggered by the HIV envelope glycoproteins. Therefore, cell death during HIV infection in CD4+ lymphocyte cultures is due to a specific event triggered by the gp120-gp41 heterodimer complex programming death in metabolically active cells.
引用
收藏
页码:761 / 773
页数:13
相关论文
共 73 条
[1]   PROGRAMMED CELL-DEATH AND AIDS - FROM HYPOTHESIS TO EXPERIMENT [J].
AMEISEN, JC .
IMMUNOLOGY TODAY, 1992, 13 (10) :388-391
[2]  
AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
[3]   DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUS IN MONONUCLEAR-CELLS BY INSITU POLYMERASE CHAIN-REACTION [J].
BAGASRA, O ;
HAUPTMAN, SP ;
LISCHNER, HW ;
SACHS, M ;
POMERANTZ, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (21) :1385-1391
[4]   CROSS-LINKING CD4 BY HUMAN IMMUNODEFICIENCY VIRUS-GP120 PRIMES T-CELLS FOR ACTIVATION-INDUCED APOPTOSIS [J].
BANDA, NK ;
BERNIER, J ;
KURAHARA, DK ;
KURRLE, R ;
HAIGWOOD, N ;
SEKALY, RP ;
FINKEL, TH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1099-1106
[5]  
CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY [J].
DEJONG, JJ ;
GOUDSMIT, J ;
KEULEN, W ;
KLAVER, B ;
KRONE, W ;
TERSMETTE, M ;
DERONDE, A .
JOURNAL OF VIROLOGY, 1992, 66 (02) :757-765
[7]   DEATH AND THE CELL [J].
DUVALL, E ;
WYLLIE, AH .
IMMUNOLOGY TODAY, 1986, 7 (04) :115-119
[8]   HUMAN AND MURINE MONOCLONAL-ANTIBODIES DIRECTED AGAINST A CONSERVED SEQUENCE FROM GP41 (AA583-599) OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
EBERSOLD, A ;
BOYER, V ;
KLASSE, PJ ;
HOLNIGUE, M ;
FRAISIER, C ;
COCCHI, JM ;
PIPKORN, R ;
BLOMBERG, J ;
DESGRANGES, C .
RESEARCH IN VIROLOGY, 1992, 143 (03) :179-191
[9]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[10]  
FAUCI A, 1991, RETROVIRUS HUMAN AID, P5